Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ken Williams

Showing results (11-20 of 102) with videos related to

Pageof 11
Sort By:
Diabetes Care|March 1, 2003
Do we need the oral glucose tolerance test to identify future cases of type 2 diabetes?Michael P Stern, Ken Williams, Steven M Haffner
Australia and New Zealand Health Policy|May 21, 2008
Access to high cost medicines in Australia: ethical perspectivesChristine Y Lu, Paul Macneill, Ken Williams, et al.
Journal of the American Geriatrics Society|March 18, 2015
Diet soda intake is associated with long-term increases in waist circumference in a biethnic cohort of older adults: the San Antonio Longitudinal Study of AgingSharon P G Fowler, Ken Williams, Helen P Hazuda
JAMA Cardiology|July 21, 2016
Risk of Premature Cardiovascular Disease vs the Number of Premature Cardiovascular EventsAllan D Sniderman, George Thanassoulis, Ken Williams, et al.
Australia and New Zealand Health Policy|December 22, 2007
The views of stakeholders on controlled access schemes for high-cost antirheumatic biological medicines in AustraliaChristine Y Lu, Jan Ritchie, Ken Williams, et al.
Diabetes Care|September 28, 2002
Predicting future cardiovascular disease: do we need the oral glucose tolerance test?Michael P Stern, Pedram Fatehi, Ken Williams, et al.
Diabetes Care|December 29, 2006
The National Cholesterol Education Program - Adult Treatment Panel III, International Diabetes Federation, and World Health Organization definitions of the metabolic syndrome as predictors of incident cardiovascular disease and diabetesCarlos Lorenzo, Ken Williams, Kelly J Hunt, et al.
Diabetes Care|June 28, 2006
Risk of progression to type 2 diabetes based on relationship between postload plasma glucose and fasting plasma glucoseMuhammad A Abdul-Ghani, Ken Williams, Ralph DeFronzo, et al.
Metabolism: Clinical and Experimental|July 10, 2009
Height, ethnicity, and the incidence of diabetes: the San Antonio Heart StudyCarlos Lorenzo, Ken Williams, Michael P Stern, et al.
Diabetes Care|March 1, 2006
Trend in the prevalence of the metabolic syndrome and its impact on cardiovascular disease incidence: the San Antonio Heart StudyCarlos Lorenzo, Ken Williams, Kelly J Hunt, et al.
Pageof 11

Showing results (11-20 of 102) with videos related to

Sort By:
Pageof 11
Diabetes Care|March 1, 2003
Do we need the oral glucose tolerance test to identify future cases of type 2 diabetes?Michael P Stern, Ken Williams, Steven M Haffner
Australia and New Zealand Health Policy|May 21, 2008
Access to high cost medicines in Australia: ethical perspectivesChristine Y Lu, Paul Macneill, Ken Williams, et al.
Journal of the American Geriatrics Society|March 18, 2015
Diet soda intake is associated with long-term increases in waist circumference in a biethnic cohort of older adults: the San Antonio Longitudinal Study of AgingSharon P G Fowler, Ken Williams, Helen P Hazuda
JAMA Cardiology|July 21, 2016
Risk of Premature Cardiovascular Disease vs the Number of Premature Cardiovascular EventsAllan D Sniderman, George Thanassoulis, Ken Williams, et al.
Australia and New Zealand Health Policy|December 22, 2007
The views of stakeholders on controlled access schemes for high-cost antirheumatic biological medicines in AustraliaChristine Y Lu, Jan Ritchie, Ken Williams, et al.
Diabetes Care|September 28, 2002
Predicting future cardiovascular disease: do we need the oral glucose tolerance test?Michael P Stern, Pedram Fatehi, Ken Williams, et al.
Diabetes Care|December 29, 2006
The National Cholesterol Education Program - Adult Treatment Panel III, International Diabetes Federation, and World Health Organization definitions of the metabolic syndrome as predictors of incident cardiovascular disease and diabetesCarlos Lorenzo, Ken Williams, Kelly J Hunt, et al.
Diabetes Care|June 28, 2006
Risk of progression to type 2 diabetes based on relationship between postload plasma glucose and fasting plasma glucoseMuhammad A Abdul-Ghani, Ken Williams, Ralph DeFronzo, et al.
Metabolism: Clinical and Experimental|July 10, 2009
Height, ethnicity, and the incidence of diabetes: the San Antonio Heart StudyCarlos Lorenzo, Ken Williams, Michael P Stern, et al.
Diabetes Care|March 1, 2006
Trend in the prevalence of the metabolic syndrome and its impact on cardiovascular disease incidence: the San Antonio Heart StudyCarlos Lorenzo, Ken Williams, Kelly J Hunt, et al.
Pageof 11